惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

爱范儿
爱范儿
腾讯CDC
博客园 - 司徒正美
A
About on SuperTechFans
H
Help Net Security
J
Java Code Geeks
C
Check Point Blog
B
Blog RSS Feed
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
MongoDB | Blog
MongoDB | Blog
U
Unit 42
Hugging Face - Blog
Hugging Face - Blog
Last Week in AI
Last Week in AI
MyScale Blog
MyScale Blog
V
Visual Studio Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
I
InfoQ
H
Hackread – Cybersecurity News, Data Breaches, AI and More
F
Fortinet All Blogs
博客园 - 聂微东
酷 壳 – CoolShell
酷 壳 – CoolShell
GbyAI
GbyAI
博客园 - 【当耐特】
雷峰网
雷峰网

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call Tr...
2026-05-08 · via All Articles on Seeking Alpha

Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call May 7, 2026 8:00 AM EDT

Company Participants

Mercedes Carrasco - Senior Director of Investor & Corporate Communications
John Butler - CEO, President & Director
Nicholas Grund - Senior VP & Chief Commercial Officer
Erik Ostrowski - Chief Business Officer, Senior VP, CFO & Treasurer
Steven Burke - Senior VP and Chief Research & Development Officer

Conference Call Participants

Julian Harrison - BTIG, LLC, Research Division
Jiale Song - Jefferies LLC, Research Division
Matthew Caufield - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to Akebia's First Quarter 2026 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Mercedes Carrasco. Please go ahead.

Mercedes Carrasco
Senior Director of Investor & Corporate Communications

Thank you, and welcome to Akebia's First Quarter 2026 Financial Results and Business Update Conference Call. Please note that a press release was issued earlier today, Thursday, May 7, detailing our first quarter 2026 financial results, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will be available on our website after we conclude.

Joining me for today's call, we have John Butler, Chief Executive Officer; Nick Grund, Chief Commercial Officer; and Erik Ostrowski, Chief Financial and Chief Business Officer. Dr. Steven Burke, our Chief Medical Officer, will also be available during Q&A.

I'd like to remind everyone that this call includes forward-looking statements. Each forward-looking statement on this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information describing these risks is included in the financial results press release that we